Our results suggest that ANRIL rs2151280 may be a potential diagnostic and prognostic marker, addressing early diagnosis of optic glioma and predicting the phenotype severity in NF1 patients. The gene discussed is CDKN2B-AS1; the disease is neurofibromatosis type 1.